Long-term Hypothyroidism in Patients Started on Levothyroxine During Pregnancy

Overview

Journal Eur Thyroid J

Specialties Endocrinology
Oncology

Date 2024 May 28

PMID 38805588

Authors

Sophie Demartin

Stefan Matei Constantinescu

Kris G Poppe

Dominique Maiter

Raluca Maria Furnica

Orsalia Alexopoulou

Chantal Daumerie

Frederic Debieve

Maria-Cristina Burlacu

Affiliations

Soon will be listed here.

Abstract

Background: Current guidelines recommend different postpartum approaches for patients started on levothyroxine (LT4) during pregnancy.

Objective: We studied the postpartum management of these patients and determined factors associated with long-term hypothyroidism.

Methods: A retrospective study was conducted at a tertiary center between 2014 and 2020, with LT4 initiation according to 2014 ETA recommendations. We performed multivariate logistic regression (MVR) and a receiver operating characteristic curve analysis to determine variables associated with long-term hypothyroidism and their optimal cutoffs.

Results: LT4 was initiated in 177 pregnant women, and 106/177 (60%) were followed at long-term (at least 6 months post partum) (28.5 (9.0-81.9) months). LT4 could have been stopped in 45% of patients who continued it immediately after delivery. Thirty-six out of 106 (34%) patients were long-term hypothyroid. In them, LT4 was initiated earlier during pregnancy than in euthyroid women (11.7 ± 4.7 vs 13.7 ± 6.5 weeks, P = 0.077), at a higher thyroid-stimulating hormone (TSH) level (4.1 (2.2-10.1) vs 3.5 (0.9-6.9) mU/L, P = 0.005), and reached a higher dose during pregnancy (62.8 ± 22.2 vs 50.7 ± 13.9 µg/day, P = 0.005). In the MVR, only the maximal LT4 dose during pregnancy was associated with long-term hypothyroidism (odds ratio (OR) = 1.03, 95% CI: 1.00-1.05, P = 0.003). The optimal cutoffs for predicting long-term hypothyroidism were an LT4 dose of 68.75 µg/day (87% specificity, 42% sensitivity; P = 0.013) and a TSH level ≥ 3.8 mU/L (68.5% specificity, 77% sensitivity; P = 0.019).

Conclusion: One-third of the patients who started on LT4 during pregnancy had long-term hypothyroidism. The TSH level at treatment initiation and the LT4 dose during pregnancy could guide the decision for continuing long-term LT4.

References

Mandel S, Larsen P, Seely E, Brent G . Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990; 323(2):91-6. DOI: 10.1056/NEJM199007123230204. View

Yassa L, Marqusee E, Fawcett R, Alexander E . Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 2010; 95(7):3234-41. DOI: 10.1210/jc.2010-0013. View

Stuckey B, Kent G, Ward L, Brown S, Walsh J . Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction. Clin Endocrinol (Oxf). 2010; 73(3):389-95. DOI: 10.1111/j.1365-2265.2010.03797.x. View

Korevaar T, Derakhshan A, Taylor P, Meima M, Chen L, Bliddal S . Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. JAMA. 2019; 322(7):632-641. PMC: 6704759. DOI: 10.1001/jama.2019.10931. View

Sun X, Hou N, Wang H, Ma L, Sun J, Liu Y . A Meta-Analysis of Pregnancy Outcomes With Levothyroxine Treatment in Euthyroid Women With Thyroid Autoimmunity. J Clin Endocrinol Metab. 2019; 105(4). DOI: 10.1210/clinem/dgz217. View

Haddow J, Palomaki G, Allan W, Williams J, Knight G, Gagnon J . Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341(8):549-55. DOI: 10.1056/NEJM199908193410801. View

Poppe K, Bisschop P, Fugazzola L, Minziori G, Unuane D, Weghofer A . 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur Thyroid J. 2021; 9(6):281-295. PMC: 7923920. DOI: 10.1159/000512790. View

Korevaar T, Steegers E, Pop V, Broeren M, Chaker L, de Rijke Y . Thyroid Autoimmunity Impairs the Thyroidal Response to Human Chorionic Gonadotropin: Two Population-Based Prospective Cohort Studies. J Clin Endocrinol Metab. 2016; 102(1):69-77. DOI: 10.1210/jc.2016-2942. View

Neelaveni K, Hari Kumar K, Sahay R, Ramesh J . Postpartum Follow-up in Women Diagnosed with Subclinical Hypothyroidism during Pregnancy. Indian J Endocrinol Metab. 2017; 21(5):699-702. PMC: 5628539. DOI: 10.4103/ijem.IJEM_452_16. View

10.

Alexander E, Pearce E, Brent G, Brown R, Chen H, Dosiou C . 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017; 27(3):315-389. DOI: 10.1089/thy.2016.0457. View

11.

Furnica R, Gruson D, Lazarus J, Maiter D, Bernard P, Daumerie C . First trimester isolated maternal hypothyroxinaemia: adverse maternal metabolic profile and impact on the obstetrical outcome. Clin Endocrinol (Oxf). 2017; 86(4):576-583. DOI: 10.1111/cen.13301. View

12.

Linardi A, Kakoulidis I, Ilias I, Michou A, Pappa A, Venaki E . Postpartum Follow-Up of Women Who Developed Subclinical Hypothyroidism during Pregnancy. Med Sci (Basel). 2020; 8(3). PMC: 7564580. DOI: 10.3390/medsci8030029. View

13.

Lazarus J, Brown R, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B . 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014; 3(2):76-94. PMC: 4109520. DOI: 10.1159/000362597. View

14.

Stagnaro-Green A . Postpartum Management of Women Begun on Levothyroxine during Pregnancy. Front Endocrinol (Lausanne). 2015; 6:183. PMC: 4663256. DOI: 10.3389/fendo.2015.00183. View

15.

Shields B, Knight B, Hill A, Hattersley A, Vaidya B . Five-year follow-up for women with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab. 2013; 98(12):E1941-5. PMC: 4207946. DOI: 10.1210/jc.2013-2768. View

16.

Maraka S, Singh Ospina N, OKeeffe D, Espinosa De Ycaza A, Gionfriddo M, Erwin P . Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016; 26(4):580-90. PMC: 4827301. DOI: 10.1089/thy.2015.0418. View

17.

Han Y, Gao X, Wang X, Zhang C, Gong B, Peng B . A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy. Thyroid. 2023; 33(5):603-614. DOI: 10.1089/thy.2022.0600. View

18.

Thangaratinam S, Tan A, Knox E, Kilby M, Franklyn J, Coomarasamy A . Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011; 342:d2616. PMC: 3089879. DOI: 10.1136/bmj.d2616. View

19.

Thompson W, Russell G, Baragwanath G, Matthews J, Vaidya B, Thompson-Coon J . Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018; 88(4):575-584. PMC: 5888183. DOI: 10.1111/cen.13550. View

20.

Toloza F, Derakhshan A, MaNnisto T, Bliddal S, Popova P, Carty D . Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2022; 10(4):243-252. PMC: 10314731. DOI: 10.1016/S2213-8587(22)00007-9. View